The Board of Directors of the Company at their Board Meeting held today considered and approved the Audited Financial Results for the quarter and financial year ended March 31, 2026 and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.6 pts less than Nifty Microcap 250 and 5.5 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
TANFAC Industries reported strong full-year results for FY 2025-26, with revenue from operations rising to Rs. 71,107.40 Lakhs from Rs. 55,698.07 Lakhs in the prior year, a ~27.7% YoY increase. Profit after tax (PAT) grew to Rs. 9,263.82 Lakhs from Rs. 7,114.29 Lakhs, up ~30.2%, while EPS stood at Rs. 35.16 per share (annualised, face value Rs. 5 post-sub-division). The Board recommended a final dividend of Rs. 4.50 per equity share (90%). The company also announced plans to set up a 20,000 MTPA downstream fluorinated product plant at an estimated cost of Rs. 495 crores, to be funded via a mix of debt and equity (QIP/private placement), with commissioning targeted within 12 months. Auditors Singhi & Co. issued an Unmodified Opinion, and the results were reviewed by the Audit Committee before Board approval.
Strong double-digit revenue and profit growth, clean audit opinion, and a new capex cycle signal confidence in the business. The QIP fundraise and new plant may dilute existing shareholders but support future revenue. The dividend provides near-term return.